Accession Number: | 0001562180-20-000881 |
Date: | 2020-01-31 |
Issuer: | AMARIN CORP PLC\UK (AMRN) |
Original Submission Date: |
KETCHUM STEVEN B
C/O AMARIN PHARMA, INC.
440 US HIGHWAY 22
BRIDGEWATER, NJ 08807
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
ORDINARY SHARES | 2020-01-31 | M | 29,000 | a | $0.00 | 482,969 | direct | ||
ORDINARY SHARES | 2020-01-31 | M | 26,000 | a | $0.00 | 508,969 | direct | ||
ORDINARY SHARES | 2020-01-31 | M | 12,734 | a | $0.00 | 521,703 | direct | ||
ORDINARY SHARES | 2020-01-31 | F | 33,603 | d | $19.04 | 488,100 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
RESTRICTED STOCK UNITS | 0.0 | 2020-01-31 | deemed execution date | M | 29,000 (d) | ordinary shares 29,000 | $0.00 | 0 | direct | |||
RESTRICTED STOCK UNITS | 0.0 | 2020-01-31 | deemed execution date | M | 26,000 (d) | ordinary shares 26,000 | $0.00 | 26,000 | direct | |||
RESTRICTED STOCK UNITS | 0.0 | 2020-01-31 | deemed execution date | M | 12,734 (d) | ordinary shares 12,734 | $0.00 | 25,466 | direct | |||
STOCK OPTION (RIGHT TO BUY) | 18.39 | 2020-02-03 | deemed execution date | A | 96,500 (a) | 2030-02-03 | ordinary shares 96,500 | $18.39 | 96,500 | direct |
ID | footnote |
---|---|
f1 | the ordinary shares may be represented by american depositary shares, each of which currently represents one ordinary share. |
f2 | on february 1, 2017, the reporting person was granted 87,000 restricted stock units ("rsus") under the amarin corporation plc 2011 stock incentive plan (the "plan"). these rsus vest in three equal installments on each of january 31, 2018, january 31, 2019, and january 31, 2020. the third and final vesting event occurred on january 31, 2020. |
f3 | not applicable. |
f4 | on february 1, 2018, the reporting person was granted 78,000 rsus under the plan. these rsus vest in three equal installments on each of january 31, 2019, january 31, 2020, and january 31, 2021. the second vesting event occurred on january 31, 2020. |
f5 | on february 1, 2019, the reporting person was granted 38,200 rsus under the plan. these rsus vest in three equal installments on each of january 31, 2020, january 31, 2021, and january 31, 2022. the first vesting event occurred on january 31, 2020. |
f6 | represents withholding by the issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with rule 16b-3, and not a market sale of securities. |
f7 | please see the section titled "remarks" below for additional information. |
f8 | each rsu represents a contingent right to receive one ordinary share or cash in lieu thereof at the issuer's discretion. |
f9 | on february 3, 2020, the reporting person was granted an option to purchase 96,500 ordinary shares under the plan. the shares subject to this option shall vest and become exercisable in 16 equal quarterly installments starting on april 30, 2020. |